AstraZeneca second quarter profit beats expectations, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The London-listed company, which reports its results in U.S. dollars, posted an adjusted profit of $2.15 per share on sales of about $11.42 billion. Analysts were expecting $1.98 per share on sales of about $10.97 billion, according to company-compiled consensus estimates., The London-listed company, which reports its results in U.S. dollars, posted an adjusted profit of $2.15 per share on sales of about $11.42 billion. Analysts were expecting $1.98 per share on sales of about $10.97 billion, according to company-compiled consensus estimates., , Read More